Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Response to Droxidopa and Atenolol in POTS
NCT03070730Phase 2Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of droxidopa in postural orthostatic tachycardia syndrome (POTS), sponsored by Beth Israel Deaconess Medical Center. Started Aug 2011; status: terminated.
02
Drugs
droxidopa
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT03070730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070730.